Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focused axisymmetric spatially chirped beams.

Optics express·2025
Same author

Development and operation of the defence COVID-19 lab as a SARS-CoV-2 diagnostic screening capability for UK military personnel.

BMJ military health·2022
Same author

Impact of antagonistic yeasts from wine grapes on growth and mycotoxin production by Alternaria alternata.

Journal of applied microbiology·2021
Same author

Genome-wide association study identifies a novel locus for cannabis dependence.

Molecular psychiatry·2017
Same author

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Cannabis and Depression: A Twin Model Approach to Co-morbidity.

Behavior genetics·2017

Related Experiment Video

Updated: Jul 7, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Beyond prostate-specific antigen: alternate serum markers.

M L Ramírez1, E C Nelson, C P Evans

  • 1Department of Urology and Cancer Center, Davis Medical Center, University of California at Davis, Sacramento, CA 95817, USA.

Prostate Cancer and Prostatic Diseases
|January 30, 2008
PubMed
Summary

Improving early prostate cancer (CaP) diagnosis requires new methods beyond prostate-specific antigen. Recent molecular assays and proteomic profiling show promise for identifying aggressive disease and improving patient outcomes.

More Related Videos

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

Related Experiment Videos

Last Updated: Jul 7, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Molecular Diagnostics

Background:

  • Current prostate cancer (CaP) diagnostic methods, including prostate-specific antigen (PSA) testing, have limitations in accurately detecting early-stage disease and predicting aggressive cancer.
  • There is a significant clinical need for improved serum-based biomarkers to enhance CaP diagnosis and risk stratification.
  • Previous research examining serum analytes as alternatives or supplements to PSA has yielded limited clinically useful data.

Purpose of the Study:

  • To review the current state of serum biomarkers for prostate cancer (CaP) diagnosis and prognosis.
  • To evaluate the benefits and limitations of existing and emerging CaP serum markers.
  • To highlight the potential of novel technologies like proteomic array profiling and DNA methylation assays.

Main Methods:

  • Literature review of existing data on serum analytes for prostate cancer detection.
  • Analysis of recent technological advancements in molecular assays and their impact on biomarker discovery.
  • Discussion of proteomic profiling and DNA methylation assays as future diagnostic and prognostic tools.

Main Results:

  • While many serum analytes have been investigated, few have demonstrated sufficient clinical utility to replace or supplement prostate-specific antigen (PSA).
  • Recent technological advances have led to the identification of prospective markers with improved specificity for CaP detection.
  • Proteomic array profiling and DNA methylation assays show considerable promise for more accurate CaP diagnosis and prognosis.

Conclusions:

  • Novel molecular assays and proteomic approaches offer significant potential for advancing prostate cancer (CaP) diagnostics and prognostics.
  • Further research and validation are needed for emerging biomarkers to establish their clinical utility.
  • The field of proteomics holds promise for discovering more accurate markers for CaP management.